The first oncological summit forum of Boao Lecheng Herun International

　　On April 27, 2024, the first oncological summit forum of Boao Lecheng Herun International was held in Boao Lecheng, hosted by Hainan Herun International Medical Health Service Co., Ltd., Shenzhen Century Tianqing Technology Co., Ltd., Sun Yat-sen University Cancer Prevention and Treatment Center, Guangdong Province Xu Kecheng Care Health Studio, Guangdong Cancer Rehabilitation Association, Southern University of Science and Technology Cell and Gene Research Center, Minzu University of China School of Environment and Life, Central South University School of Life Sciences, Jinan University Hydrogen Medicine Research Institute, Guangzhou Dabo Biological Products Co., Ltd., and Guangdong Xiankangda Biotechnology Co., Ltd. .

　　This forum was held online and offline, dedicated to exploring more effective diagnosis and treatment paths, and strengthening the exchange of experience and sharing of research results in the field of integrated medicine and precision medicine for tumors in my country.

　　Academic grand gathering

　　Gao Jinghua, chairman of Herun International Medical, attended the forum and announced the opening of the forum. Professor Xu Kecheng, President of Guangzhou Fuda Cancer Hospital, Huang Wenlin, Academician of European Academy of Natural Sciences and Professor of Sun Yat-sen University Cancer Hospital, Li Dinggang, Chief Clinical Medicine Expert of Cell and Gene Research Center of Southern University of Science and Technology, Zhao Baisong, Executive Director of Cell and Gene Therapy Research Center of Southern University of Science and Technology, Chen Lei, Ph.D. of Minzu University of China, Li Jiada, Professor and Vice Dean of School of Life Sciences of Central South University, Kong Xiaofeng, Vice Dean of Translational Research Institute and Hydrogen Medical Research Institute of School of Biomedical Sciences of Jinan University, Yang Wei, Medical Director of Xiankangda Group, etc. attended the forum and delivered speeches. The meeting was chaired by Professor Li Dinggang of Southern University of Science and Technology.

　　More than 200 people including workers from medical and health care industries, well-known experts and scholars at home and abroad, and corporate representatives attended the forum.

　　Speeches by leaders and experts

　　Speeches by leaders and experts

Gao Jinghua, Chairman of Herun International Medical

　　Gao Jinghua, Chairman of Herun International Medical, expressed his sincere welcome to all the guests attending the forum! Gao Jinghua said in his speech that the goal of holding the "Boao Lecheng Herun International First Tumor Summit Forum" is to jointly explore the future development of tumor prevention and treatment and contribute to the health of mankind. Gao Jinghua pointed out that we hope to build a high-end and professional communication platform so that medical experts and all friends who care about tumor prevention and treatment can gather together to communicate, share experiences and collide ideas. On this platform, the latest research results and technological progress in tumor prevention and treatment will be displayed, successful cases and practical experience will be shared, and the future development trend of tumor prevention will be discussed together.

　　Xu Kecheng, founder of Guangzhou Fuda Cancer Hospital, well-known gastroenterologist and tumor treatment expert, gave an academic report entitled "A new Cancer compound Immunotherapy CCI A new type of cancer compound immunotherapy (MBV, MV, TTV, ACCV)".

　　Huang Wenlin, academician of the European Academy of Natural Sciences and professor of Sun Yat-sen University Cancer Hospital, gave an academic report entitled "Research and Development and Clinical Transformation of NK Cell Therapy Products".

　　Li Dinggang, chief clinical medicine expert of the Cell and Gene Research Center of Southern University of Science and Technology, gave an academic report entitled "P53 Gene Detection and Cancer Prevention and Treatment".

　　Zhao Baisong, executive director of the Cell and Gene Therapy Research Center of Southern University of Science and Technology, gave an academic report entitled "Exploration, Practice and Clinical Application of TILs in the Treatment of Solid Tumors".

　　Chen Lei, a doctoral student at Minzu University of China and an expert in the field of neurological and psychiatric diseases, gave an academic report entitled "Exosomes, a new treatment strategy for neuropsychological and psychiatric diseases".

　　Li Jiada, professor, vice dean and doctoral supervisor of the School of Life Sciences of Central South University, gave an academic report entitled "Application of iNKT Immunotherapy".

　　Kong Xiaofeng, vice dean of the Translational Research Institute and Hydrogen Medical Research Institute of the School of Biomedical Sciences of Jinan University, gave an academic report entitled "Clinical Application Experience and Practice of Cancer Composite Immunotherapy".

　　Yang Wei, medical director of Xiankangda Group, gave an academic report entitled "Progress and Thinking of Allogeneic NK in Tumor Treatment".

　　Forum Conclusion

　　This event brought together the top experts and scholars in China, who shared wisdom, exchanged ideas, and jointly promoted the progress in the field of oncology medicine. We examined the forefront of tumor research from an international perspective, brought participants thoughts and inspiration on tumor diagnosis and treatment strategies, and pointed out the direction for future development. Let us work together to continue exploring and innovating on the road ahead and write a more glorious chapter for the cause of human health!